Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “multiple sclerosis”
Sponsor: Hoffmann-La Roche
Multiple Sclerosis
Germany, Switzerland
Sponsor: Region Stockholm
Multiple Sclerosis
Sweden
Sponsor: Koç University
Multiple Sclerosis, MS
Turkey (Türkiye)
Sponsor: Hoffmann-La Roche
Multiple Sclerosis
United States, Belgium, Canada, Germany, Israel +7 more
Sponsor: Queen Mary University of London
Multiple Sclerosis
United Kingdom
- Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple SclerosisActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Multiple Sclerosis
United States, Germany, Italy, Poland, United Kingdom
Sponsor: Kessler Foundation
Multiple Sclerosis, Relapsing-Remitting
United States
Sponsor: Slb Pharma
Neurological Conditions · Brain Diseases · Cerebral Palsy · Parkinson Disease (PD)
France
Sponsor: Biogen
Multiple Sclerosis
United States, Australia, Germany, Ireland, Spain +2 more
Sponsor: Hoffmann-La Roche
Relapsing Multiple Sclerosis · Primary Progressive Multiple Sclerosis
United States, Brazil, Czechia, Italy, New Zealand +3 more
- Multiple Sclerosis Falls Insight TrackActive Not Recruiting
Sponsor: University of California, San Francisco
Multiple Sclerosis
United States
Sponsor: Washington University School of Medicine
Multiple Sclerosis (MS) - Relapsing-remitting
United States
Sponsor: Kessler Foundation
Multiple Sclerosis, Relapsing-Remitting
United States
- Prospective Evaluation of De-Escalation From antiCD-20 Therapies to Dimethyl Fumarate (Tecfidera) or Diroximel Fumarate (Vumerity)Active Not Recruiting
Sponsor: University of Colorado, Denver
Multiple Sclerosis (MS) Relapsing Remitting
United States
Sponsor: Hoffmann-La Roche
Relapsing Multiple Sclerosis
Argentina, Brazil, Mexico, Poland, Portugal +2 more
Sponsor: University of California, San Francisco
Multiple Sclerosis · Clinically Isolated Syndrome · NMOSD · Myasthenia Gravis
United States
- Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple SclerosisActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Multiple Sclerosis
United States, Australia, Austria, Brazil, Bulgaria +20 more
- Phase Ib/II Study of SYS6020 in Relapsing/Refractory Multiple SclerosisNot Yet Recruiting
Sponsor: Tongji Hospital
Multiple Sclerosis
China
- Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of OfatumumabActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Relapsing Multiple Sclerosis (RMS)
United States, Puerto Rico
- Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register StudyActive Not Recruiting
Sponsor: Kuopio University Hospital
Neurodegenerative Diseases · Alzheimer Disease · Frontotemporal Dementia · Lewy Body Disease
Finland
Sponsor: Sovargen
Focal Cortical Dysplasia · Tuberous Sclerosis Complex (TSC) · Hemimegalencephaly
Australia
- A Study of KYV-101, a CD19 CAR T Cell Therapy, in Participants With Treatment Refractory Progressive Multiple SclerosisActive Not Recruiting
Sponsor: Bruce Cree
Progressive Multiple Sclerosis
United States
Sponsor: Novartis Pharmaceuticals
Relapsing Multiple Sclerosis
United States, Argentina, Australia, Belgium, Brazil +14 more
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Tuberous Sclerosis
United States
- Autoimmune Intervention Mastery Course StudyActive Not Recruiting
Sponsor: Terry L. Wahls
Multiple Sclerosis · Clinically Isolated Syndrome · Fibromyalgia · Post Acute Sequelae of COVID-19
United States